stockrow
Saturday 7 November 2026
Export TBIO’s income statement to Excel — free account
Telesis Bio Inc.
TBIO Healthcare Medical Devices
Telesis Bio Inc.’s revenue for fiscal 2023 (year ended December 2023) was $27.5 million, roughly unchanged from fiscal 2022.
0.01
0.00
0.00%
Follow TBIO
Alert me
Telesis Bio Inc. (TBIO) P/E ratio
Telesis Bio Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2024 | 0.0× | — |
| Jun 2024 | 0.0× | — |
| Mar 2024 | 0.0× | — |
| Dec 2023 | 0.0× | — |
| 14 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TNON Tenon Medical, Inc. compare | n/m |
| INBS Intelligent Bio Solutions Inc. compare | n/m |
| TRIB Trinity Biotech PLC compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| VNRX VolitionRX Limited compare | n/m |
| TBIO Telesis Bio Inc. | n/m |
| BMRA Biomerica, Inc. compare | n/m |
| NVNO enVVeno Medical Corporation compare | n/m |
| WOK WORK Medical Technology Group LTD compare | — |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)